Ovotesticular syndrome
| Ovotesticular syndrome | |
|---|---|
| Synonyms | True hermaphroditism |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Ambiguous genitalia, presence of both ovarian and testicular tissue |
| Complications | Infertility, gonadal tumors |
| Onset | Congenital |
| Duration | Lifelong |
| Types | N/A |
| Causes | Genetic mutation, chromosomal abnormalities |
| Risks | Family history, certain genetic syndromes |
| Diagnosis | Karyotype analysis, hormone levels, imaging studies, biopsy |
| Differential diagnosis | Androgen insensitivity syndrome, Congenital adrenal hyperplasia |
| Prevention | N/A |
| Treatment | Hormone therapy, surgical intervention |
| Medication | N/A |
| Prognosis | Variable, depending on the presence of complications |
| Frequency | Rare |
| Deaths | N/A |
Ovotesticular Disorder of Sex Development (DSD), formerly known as True Hermaphroditism, is a rare condition characterized by the presence of both ovarian and testicular tissue in the same individual. This condition falls under the broader category of disorders of sex development, which encompasses a variety of conditions involving atypical development of physical sex characteristics.
Overview[edit]
Ovotesticular DSD is the rarest form of DSD, with individuals having both ovarian and testicular tissues. These tissues can be separate as an ovary and a testis, or combined in what is known as an ovotestis. The distribution of ovarian and testicular tissue varies among individuals, leading to a wide spectrum of genital presentations. This can range from predominantly female external genitalia to predominantly male, with many cases presenting ambiguous genitalia.
Causes[edit]
The exact cause of Ovotesticular DSD is not fully understood, but it is believed to involve genetic abnormalities. Chromosomal configurations can vary widely among individuals with this condition, including typical male (46,XY), typical female (46,XX), and mixed or mosaic patterns (e.g., 46,XX/46,XY).
Diagnosis[edit]
Diagnosis of Ovotesticular DSD involves a combination of clinical evaluation, imaging studies, and genetic testing. Physical examination may reveal ambiguous genitalia or features typical of both sexes. Imaging studies, such as ultrasound or MRI, can help identify the presence and location of ovarian and testicular tissues. Genetic testing can provide information on chromosomal sex and identify any genetic abnormalities.
Management[edit]
Management of Ovotesticular DSD is highly individualized and may involve a multidisciplinary team including endocrinologists, surgeons, psychologists, and genetic counselors. Decisions regarding potential surgery, such as the removal of discordant gonadal tissue or genital reconstruction, are made on a case-by-case basis, taking into account the individual's age, overall health, and personal or family preferences regarding gender identity and fertility potential.
Social and Psychological Aspects[edit]
Individuals with Ovotesticular DSD may face social and psychological challenges, including issues related to gender identity, social acceptance, and fertility. Support from healthcare providers, counselors, and support groups can be crucial in navigating these challenges.
Conclusion[edit]
Ovotesticular DSD is a complex condition requiring a comprehensive and sensitive approach to diagnosis and management. Advances in medical science and increased awareness of the diversity of human sex development are improving the care and understanding of individuals with this and related conditions.
NIH genetic and rare disease info[edit]
Ovotesticular syndrome is a rare disease.
| Rare and genetic diseases | ||||||
|---|---|---|---|---|---|---|
|
Rare diseases - Ovotesticular syndrome
|